Balance Sheet
Accounts PayablesAccumulated ExpensesAssetsCash & Current InvestmentsCash & EquivalentsCommon EquityCurrent AssetsCurrent LeasesFinished GoodsGoodwill & IntangiblesIntangiblesInventoryLiabilities and Shareholders EquityLong-Term InvestmentsNon-Current AssetsNon-Current DebtOperating LeasesOther Accumulated ExpensesOther Non-Current AssetsPayablesPreferred Stock LiabilitiesPrepaid AssetsProperty, Plant & Equipment (Net)Raw MaterialsReceivablesReceivables - NetRetained EarningsShareholder's EquityShort term DebtShort-term InvestmentsTotal Current LiabilitiesTotal DebtTotal LiabilitiesWork In Process
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Rhythm Pharmaceuticals (RYTM) Short term Debt (2016 - 2025)

Historic Short term Debt for Rhythm Pharmaceuticals (RYTM) over the last 3 years, with Q3 2025 value amounting to $5.6 million.

  • Rhythm Pharmaceuticals' Short term Debt changed N/A to $5.6 million in Q3 2025 from the same period last year, while for Sep 2025 it was $5.6 million, marking a year-over-year change of. This contributed to the annual value of $1.5 million for FY2024, which is N/A changed from last year.
  • As of Q3 2025, Rhythm Pharmaceuticals' Short term Debt stood at $5.6 million.
  • Rhythm Pharmaceuticals' 5-year Short term Debt high stood at $5.6 million for Q3 2025, and its period low was $1.5 million during Q4 2024.